Radboud University Medical Center Becomes First Hospital in the Netherlands to Win HIMSS Stage 7 Award

HIMSS EuropeHIMSS Analytics Europe, subsidiary of HIMSS Europe, has awarded Radboud university medical center with the Stage 7 Award, making it the first HIMSS Stage 7 hospital in the Netherlands and the third in Europe.

The hospital, which has 953 beds, joins the University Medical Centre Hamburg-Eppendorf in Germany and the Hospital de Dénia-Marina Salud in Spain in the highest stage of the European EMR Adoption Model (EMRAM) developed by HIMSS.

The Netherlands enjoy a high number of Stage 6 awarded hospitals, which consolidates this country as one of the European leaders in ehealth. Beside Radboudumc, as of today, 10 Dutch hospitals and university medical centers have achieved Stage 6. Across Europe there are more than 50 hospitals recognized in the Stage 6 category.

EMRAM has been adapted to meet the needs of European healthcare institutions as a methodology for evaluating the progress and impact of electronic medical record systems in hospitals. Tracking their progress in completing eight stages (0‐7), hospitals can review the implementation and utilization of information technology applications with the aim of reaching Stage 7, which represents a superior electronic patient record environment.

Hospitals that reach Stage 7 support the true sharing and use of patient data to improve process performance, quality of care and patient safety. Uwe Buddrus, senior consultant at HIMSS Analytics Europe, said: "Radboudumc is only the third hospital in Europe to achieve the prestigious HIMSS EMRAM Stage 7 Award and the first within two years during which many European hospitals - more than 1100 in Europe, 62 of which in The Netherlands - participated in the EMRAM evaluation. I am very happy that HIMSS has identified another best practice example in Europe, which I am sure will stimulate many other hospitals on their journey towards improving healthcare delivery by the use of hospital IT solutions."

Buddrus adds: "Radboudumc is also the first fully approved member of the HIMSS Stage 6 & 7 Club, and expected to take a leading role in providing continuous evidence of the benefits of IT. Among the many highlights of Radboudumc's achievements since its last evaluation and recognition as Stage 6, I'd like to emphasize their approach towards medication safety, as well as Clinical Decision Support."

For more information on the stage 7 award visit http://himssanalytics.eu/emram/

About HIMSS Analytics Europe
HIMSS Analytics Europe (HAE) provides health care organisations, governments and industry with extensive data resources and services about the adoption and use of healthcare information technology in Europe. HAE’s offerings include comparative Hospital IT adoption benchmarking, a European‐formulated EMR Adoption Model (EMRAM) scale, and other resources to help hospital directors, IT executives and clinicians compare and measure their progress and how they compare to others. Country level and application specific reports also provide insights into major IT adoption trends and applications.

About Radboud university medical centre
Radboud university medical center founded in 1951, is an institute for patient care, research and education & training, located in Nijmegen in the Netherlands. Our mission is to have a significant impact on healthcare. We aim to be a frontrunner in the development of innovative, sustainable and affordable healthcare. We offer excellent quality, participatory and personalised healthcare, operational excellence and sustainable networks. Our almost 10,000 employees and over 3,000 students do their utmost every day to make a positive contribution to the future of healthcare and medical sciences.

Most Popular Now

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

New AI Approach Paves Way for Smarter T-…

Researchers have harnessed the power of artificial intelligence (AI) to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...